Global Colorectal Cancer Therapeutics Market 2022-2026

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	120 Pages	TechNavio	March, 2022	INF17046445

Best Price Guarantee
Price	from $2,500
Length	120 Pages
Publisher	TechNavio
Published Date	March, 2022
SKU	INF17046445

Global Colorectal Cancer Therapeutics Market 2022-2026

Technavio has been monitoring the colorectal cancer therapeutics market and it is poised to grow by $ 2.45 bn during 2022-2026 progressing at a CAGR of 5.43% during the forecast period. Our report on the colorectal cancer therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing geriatric population, rising occurrence of colorectal cancer, and introduction of combination therapeutics.

The colorectal cancer therapeutics market analysis includes type segment and geographic landscape.

Technavio's colorectal cancer therapeutics market is segmented as below:

By Type

Targeted therapy
Immunotherapy
Chemotherapy

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the development of small molecule kinase inhibitors as one of the prime reasons driving the colorectal cancer therapeutics market growth during the next few years. Also, the advent of gene therapy and personalized therapeutics will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the colorectal cancer therapeutics market covers the following areas:

Colorectal cancer therapeutics market sizing
Colorectal cancer therapeutics market forecast
Colorectal cancer therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading colorectal cancer therapeutics market vendors that include Accord Healthcare Ltd., Amgen Inc., Amneal Pharmaceuticals Inc., Bayer AG, Biocon Ltd., Bristol-Myers Squibb Co., CK Hutchison Holdings Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius SE, and Co. KGaA, Hetero Drugs Ltd., Hikma Pharmaceuticals Plc, Merck and Co. Inc., Ono Pharmaceutical Co. Ltd., Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc. Also, the colorectal cancer therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Companies Mentioned

Accord Healthcare Ltd., Amgen Inc., Amneal Pharmaceuticals Inc., Bayer AG, Biocon Ltd., Bristol-Myers Squibb Co., CK Hutchison Holdings Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Hetero Drugs Ltd., Hikma Pharmaceuticals Plc, Merck and Co. Inc., Ono Pharmaceutical Co. Ltd., Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc.

Executive Summary
- Market overview
  - Table Executive Summary – Chart on Market Overview
  - Table Executive Summary – Data Table on Market Overview
  - Table Executive Summary – Chart on Global Market Characteristics
  - Table Executive Summary – Chart on Market by Geography
  - Table Executive Summary – Chart on Market Segmentation by Type
  - Table Executive Summary – Chart on Incremental Growth
  - Table Executive Summary – Data Table on Incremental Growth
  - Table Executive Summary – Chart on Vendor Market Positioning
Market Landscape
- Market ecosystem
  - Table Parent market
  - Table Market Characteristics
Market Sizing
- Market definition
  - Table Offerings of vendors included in the market definition
- Market segment analysis
  - Table Market segments
- Market size 2021
- Market outlook: Forecast for 2021-2026
  - Table Chart on Global - Market size and forecast 2021-2026 ($ million)
  - Table Data Table on Global - Market size and forecast 2021-2026 ($ million)
  - Table Chart on Global Market: Year-over-year growth 2021-2026 (%)
  - Table Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Five Forces Analysis
- Five forces summary
  - Table Five forces analysis - Comparison between 2021 and 2026
- Bargaining power of buyers
  - Table Bargaining power of buyers – Impact of key factors in 2021 and 2026
- Bargaining power of suppliers
  - Table Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- Threat of new entrants
  - Table Threat of new entrants – Impact of key factors in 2021 and 2026
- Threat of substitutes
  - Table Threat of substitutes – Impact of key factors in 2021 and 2026
- Threat of rivalry
  - Table Threat of rivalry – Impact of key factors in 2021 and 2026
- Market condition
  - Table Chart on Market condition - Five forces 2021 and 2026
Market Segmentation by Type
- Market segments
  - Table Chart on Type - Market share 2021-2026 (%)
  - Table Data Table on Type - Market share 2021-2026 (%)
- Comparison by Type
  - Table Chart on Comparison by Type
  - Table Data Table on Comparison by Type
- Targeted therapy - Market size and forecast 2021-2026
  - Table Chart on Targeted therapy - Market size and forecast 2021-2026 ($ million)
  - Table Data Table on Targeted therapy - Market size and forecast 2021-2026 ($ million)
  - Table Chart on Targeted therapy - Year-over-year growth 2021-2026 (%)
  - Table Data Table on Targeted therapy - Year-over-year growth 2021-2026 (%)
- Immunotherapy - Market size and forecast 2021-2026
  - Table Chart on Immunotherapy - Market size and forecast 2021-2026 ($ million)
  - Table Data Table on Immunotherapy - Market size and forecast 2021-2026 ($ million)
  - Table Chart on Immunotherapy - Year-over-year growth 2021-2026 (%)
  - Table Data Table on Immunotherapy - Year-over-year growth 2021-2026 (%)
- Chemotherapy - Market size and forecast 2021-2026
  - Table Chart on Chemotherapy - Market size and forecast 2021-2026 ($ million)
  - Table Data Table on Chemotherapy - Market size and forecast 2021-2026 ($ million)
  - Table Chart on Chemotherapy - Year-over-year growth 2021-2026 (%)
  - Table Data Table on Chemotherapy - Year-over-year growth 2021-2026 (%)
- Market opportunity by Type
  - Table Market opportunity by Type ($ million)
Customer Landscape
- Customer landscape overview
  - Table Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Geographic Landscape
- Geographic segmentation
  - Table Chart on Market share by geography 2021-2026 (%)
  - Table Data Table on Market share by geography 2021-2026 (%)
- Geographic comparison
  - Table Chart on Geographic comparison
  - Table Data Table on Geographic comparison
- North America - Market size and forecast 2021-2026
  - Table Chart on North America - Market size and forecast 2021-2026 ($ million)
  - Table Data Table on North America - Market size and forecast 2021-2026 ($ million)
  - Table Chart on North America - Year-over-year growth 2021-2026 (%)
  - Table Data Table on North America - Year-over-year growth 2021-2026 (%)
- Europe - Market size and forecast 2021-2026
  - Table Chart on Europe - Market size and forecast 2021-2026 ($ million)
  - Table Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  - Table Chart on Europe - Year-over-year growth 2021-2026 (%)
  - Table Data Table on Europe - Year-over-year growth 2021-2026 (%)
- Asia - Market size and forecast 2021-2026
  - Table Chart on Asia - Market size and forecast 2021-2026 ($ million)
  - Table Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  - Table Chart on Asia - Year-over-year growth 2021-2026 (%)
  - Table Data Table on Asia - Year-over-year growth 2021-2026 (%)
- Rest of World (ROW) - Market size and forecast 2021- 2026
  - Table Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  - Table Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  - Table Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  - Table Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- US - Market size and forecast 2021-2026
  - Table Chart on US - Market size and forecast 2021-2026 ($ million)
  - Table Data Table on US - Market size and forecast 2021-2026 ($ million)
  - Table Chart on US - Year-over-year growth 2021-2026 (%)
  - Table Data Table on US - Year-over-year growth 2021-2026 (%)
- Germany - Market size and forecast 2021-2026
  - Table Chart on Germany - Market size and forecast 2021-2026 ($ million)
  - Table Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  - Table Chart on Germany - Year-over-year growth 2021-2026 (%)
  - Table Data Table on Germany - Year-over-year growth 2021-2026 (%)
- UK - Market size and forecast 2021-2026
  - Table Chart on UK - Market size and forecast 2021-2026 ($ million)
  - Table Data Table on UK - Market size and forecast 2021-2026 ($ million)
  - Table Chart on UK - Year-over-year growth 2021-2026 (%)
  - Table Data Table on UK - Year-over-year growth 2021-2026 (%)
- Canada - Market size and forecast 2021-2026
  - Table Chart on Canada - Market size and forecast 2021-2026 ($ million)
  - Table Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  - Table Chart on Canada - Year-over-year growth 2021-2026 (%)
  - Table Data Table on Canada - Year-over-year growth 2021-2026 (%)
- China - Market size and forecast 2021-2026
  - Table Chart on China - Market size and forecast 2021-2026 ($ million)
  - Table Data Table on China - Market size and forecast 2021-2026 ($ million)
  - Table Chart on China - Year-over-year growth 2021-2026 (%)
  - Table Data Table on China - Year-over-year growth 2021-2026 (%)
- Market opportunity by geography
  - Table Market opportunity by geography ($ million)
Drivers, Challenges, and Trends
- Market drivers
  - Increasing geriatric population
  - Rising occurrence of colorectal cancer
  - Introduction of combination therapeutics
- Market challenges
  - Patent expiration of novel therapeutics
  - Availability of alternative therapies
  - Side effects associated with available medicines
- Impact of drivers and challenges
  - Table Impact of drivers and challenges in 2021 and 2026
- Market trends
  - Development of small molecule kinase inhibitors
  - Advent of gene therapy
  - Personalized therapeutics
Vendor Landscape
- Overview
- Vendor landscape
  - Table Overview on Criticality of inputs and Factors of differentiation
- Landscape disruption
  - Table Overview on factors of disruption
- Industry risks
  - Table Impact of key risks on business
Vendor Analysis
- Vendors covered
  - Table Vendors covered
- Market positioning of vendors
  - Table Matrix on vendor position and classification
- Amgen Inc.
  - Table Amgen Inc. –Overview
  - Table Amgen Inc. - Business segments
  - Table Amgen Inc. - Key offerings
  - Table Amgen Inc. - Segment focus
- Bayer AG
  - Table Bayer AG – Overview
  - Table Bayer AG - Business segments
  - Table Bayer AG - Key news
  - Table Bayer AG - Key offerings
  - Table Bayer AG - Segment focus
- Biocon Ltd.
  - Table Biocon Ltd. –Overview
  - Table Biocon Ltd. - Business segments
  - Table Biocon Ltd. - Key offerings
  - Table Biocon Ltd. - Segment focus
- Bristol-Myers Squibb Co.
  - Table Bristol-Myers Squibb Co. –Overview
  - Table Bristol-Myers Squibb Co. - Product / Service
  - Table Bristol-Myers Squibb Co. - Key offerings
- Eli Lilly and Co.
  - Table Eli Lilly and Co. –Overview
  - Table Eli Lilly and Co. - Business segments
  - Table Eli Lilly and Co. - Key offerings
  - Table Eli Lilly and Co. - Segment focus
- F. Hoffmann La Roche Ltd.
  - Table F. Hoffmann La Roche Ltd. –Overview
  - Table F. Hoffmann La Roche Ltd. - Business segments
  - Table F. Hoffmann La Roche Ltd. - Key news
  - Table F. Hoffmann La Roche Ltd. - Key offerings
  - Table F. Hoffmann La Roche Ltd. - Segment focus
- Fresenius SE and Co. KGaA
  - Table Fresenius SE and Co. KGaA – Overview
  - Table Fresenius SE and Co. KGaA - Business segments
  - Table Fresenius SE and Co. KGaA - Key offerings
  - Table Fresenius SE and Co. KGaA - Segment focus
- Merck and Co. Inc.
  - Table Merck and Co. Inc. –Overview
  - Table Merck and Co. Inc. - Business segments
  - Table Merck and Co. Inc. - Key news
  - Table Merck and Co. Inc. - Key offerings
  - Table Merck and Co. Inc. - Segment focus
- Sanofi SA
  - Table Sanofi SA – Overview
  - Table Sanofi SA - Business segments
  - Table Sanofi SA - Key news
  - Table Sanofi SA - Key offerings
  - Table Sanofi SA - Segment focus
- Viatris Inc.
  - Table Viatris Inc. –Overview
  - Table Viatris Inc. - Business segments
  - Table Viatris Inc. - Key offerings
  - Table Viatris Inc. - Segment focus
Appendix
- Scope of the report
  - Market definition
  - Objectives
  - Notes and caveats
- Inclusions and exclusions checklist
  - Table Inclusions checklist
  - Table Exclusions checklist
- Currency conversion rates for US$
  - Table Currency conversion rates for US$
- Research methodology
  - Table Research methodology
  - Table Validation techniques employed for market sizing
  - Table Information sources
- List of abbreviations
  - Table List of abbreviations